VANGUARD GROUP INC - FULCRUM THERAPEUTICS INC ownership

FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 111 filers reported holding FULCRUM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.6%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of FULCRUM THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$19,041,086
-20.5%
3,071,143
+21.0%
0.00%
Q1 2024$23,964,998
+40.9%
2,538,665
+0.7%
0.00%
Q4 2023$17,009,892
+44.9%
2,519,984
-4.7%
0.00%
Q3 2023$11,735,786
+35.4%
2,643,195
+0.7%
0.00%
Q2 2023$8,665,895
+5.6%
2,626,029
-8.8%
0.00%
Q1 2023$8,203,699
-46.9%
2,878,491
+35.7%
0.00%
Q4 2022$15,438,135
-2.4%
2,120,623
+8.4%
0.00%
Q3 2022$15,825,000
+111.1%
1,956,092
+27.9%
0.00%
Q2 2022$7,495,000
-78.9%
1,529,662
+1.7%
0.00%
-100.0%
Q1 2022$35,565,000
+36.9%
1,503,821
+2.4%
0.00%0.0%
Q4 2021$25,981,000
-26.5%
1,468,659
+17.2%
0.00%0.0%
Q3 2021$35,359,000
+272.0%
1,253,426
+38.2%
0.00%
Q2 2021$9,505,000
-4.3%
907,035
+7.6%
0.00%
Q1 2021$9,933,000
+28.3%
843,195
+27.5%
0.00%
Q4 2020$7,743,000
+60.9%
661,206
+9.0%
0.00%
Q3 2020$4,811,000
-38.1%
606,552
+42.8%
0.00%
Q2 2020$7,768,000
+461.3%
424,738
+266.4%
0.00%
Q1 2020$1,384,000
+12.7%
115,917
+57.0%
0.00%
Q4 2019$1,228,000
+1058.5%
73,834
+361.5%
0.00%
Q3 2019$106,00015,9970.00%
Other shareholders
FULCRUM THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
TRV GP III, LLC 3,962,202$70,091,00017.54%
TRV GP IV, LLC 2,343,154$41,450,00011.92%
ACUTA CAPITAL PARTNERS, LLC 200,000$3,538,0001.49%
HighVista Strategies LLC 89,963$1,591,0001.27%
Logos Global Management LP 685,000$12,118,0001.25%
Monashee Investment Management LLC 273,045$4,830,0001.19%
RTW INVESTMENTS, LP 3,866,872$68,405,0001.00%
Parkman Healthcare Partners LLC 250,106$4,424,0000.98%
Deep Track Capital, LP 750,000$13,268,0000.94%
Darwin Global Management, Ltd. 317,428$5,615,0000.86%
View complete list of FULCRUM THERAPEUTICS INC shareholders